Skip to main content
SpringerLink
Log in

Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia

  • Cardiac
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

The aim of the study was to evaluate safety and feasibility of dobutamine cardiovascular magnetic resonance (CMR) in patients with proven or suspected coronary artery disease. Dobutamine CMR was evaluated retrospectively in 400 consecutive patients with suspicion of myocardial ischemia. Dobutamine was infused using an incremental protocol up to 40 μg/kg body weight per minute. All anti-anginal medication was stopped 4 days before the CMR study and infusion time of dobutamine was 6 min per stage. Hemodynamic data, CMR findings and side effects were reported. Patients with contraindications to CMR (metallic implants and claustrophobia) were excluded from analysis. Dobutamine CMR was successfully performed in 355 (89%) patients. Forty-five (11%) patients could not be investigated adequately because of non-cardiac side effects in 29 (7%) and cardiac side effects in 16 (4%) patients. Hypotension (1.5%) and arrhythmias (1%) were the most frequent cardiac side effects. One patient developed a severe complication (ventricular fibrillation) at the end of the study. There were no myocardial infarctions or fatal complications of the stress test. The most frequent non-cardiac side effects were nausea, vomiting and claustrophobia. Age >70 years, prior myocardial infarction and rest wall motion abnormalities showed no significant differences with side effects (P>0.05). Dobutamine CMR is safe and feasible in patients with suspicion of myocardial ischemia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Pennell DJ, Underwood SR, Manzara CC, Swanton RH, Walker JM, Ell PJ, Longmore DB (1992) Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 70:34–40

    Article  CAS  PubMed  Google Scholar 

  2. Nagel E, Lehmkuhl HB, Bocksch W, Klein C, Vogel U, Frantz E, Ellmer A, Dreysse S, Fleck E (1999) Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 99:763–770

    CAS  PubMed  Google Scholar 

  3. Hundley WG, Hamilton CA, Thomas MS, Herrington DM, Salido TB, Kitzman DW, Little WC, Link KM (1999) Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 100:1697–1702

    CAS  PubMed  Google Scholar 

  4. Kuijpers D, Ho KYJAM, Dijkman PRM van, Vliegenthart R, Oudkerk M (2003) Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia using myocardial tagging. Circulation 107:1592–1597

    Article  PubMed  Google Scholar 

  5. American Heart Association, American College of Cardiology (1997) Guidelines for exercise testing. J Am Coll Cardiol 30:260–315

    Google Scholar 

  6. American Heart Association, American College of cardiology (2002) Guideline update for exercise testing. Circulation 106:1883–1892

    Google Scholar 

  7. Lipton MJ, Bogaert J, Boxt LM, Reba RC (2002) Imaging of ischemic heart disease. Eur Radiol 12:1061–1080

    Article  PubMed  Google Scholar 

  8. Sandstede JJ (2003) Assessment of myocardial viability by MR imaging. Eur Radiol 13:52–61

    PubMed  Google Scholar 

  9. Dewey M, Borges AC, Kivelitz D, Taupitz M, Wagner S, Baumann G, Hamm B (2004) Coronary artery disease: new insights and their implications for radiology. Eur Radiol 14:1048–1054

    Article  PubMed  Google Scholar 

  10. Hundley WG, Morgan TM, Neagle CM, Hamilton CA, Rerkpattanapipat P, Link KM (2002) Magnetic resonance imaging determination of cardiac prognosis. Circulation 106:2328–2333

    Article  PubMed  Google Scholar 

  11. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Circulation 105:539–542

    Article  PubMed  Google Scholar 

  12. Sheffield LT (1988) Exercise stress test. In: Braunwald E (ed) Heart disease: a textbook of cardiovascular medicine, 4th edn. Saunders, Philadelphia, pp 223–241

    Google Scholar 

  13. Secknus MA, Marwick TH (1997) Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 29:1234–1240

    Article  CAS  PubMed  Google Scholar 

  14. Picano E, Mathias WJ, Pingitore A, Bigi R, Previtali M (1994) Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective multicentre study. Echo dobutamine international cooperative study group. Lancet 344:1190–1192

    Article  CAS  PubMed  Google Scholar 

  15. Mertes H, Sawada SG, Ryan T, Segar DS, Kovacs R, Foltz J, Feigenbaum H (1993) Symptoms, adverse effects and complications associated with dobutamine stress echocardiography. Experience in 1118 patients. Circulation 88:15–19

    CAS  PubMed  Google Scholar 

  16. Zoghbi WA, Barasch E (1999) Dobutamine MRI: a serious contender in pharmacological stress imaging. Circulation 99:730–732

    CAS  PubMed  Google Scholar 

  17. Nesto RW, Kowalchuk GJ (1987) The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and sypmtomaric expressions of ischemia. Am J Cardiol 59:23C–30C

    Article  CAS  PubMed  Google Scholar 

  18. Heyndrikx CR, Baic H, Nelkins P (1978) Depression of regional blood flow and wall thickening after brief coronary occlusion. Am J Physiol 234:653–660

    Google Scholar 

  19. Nagel E, Schneider U, Schall S, Ibrahim T, Schnackenburg B, Bornstedt A, Klein C, Lehmkuhl HB, Fleck E (2000) Magnetic resonance real time imaging for the evaluation of left ventricular function. J Cardiovasc Magn Reson 2:7–14

    CAS  PubMed  Google Scholar 

  20. Schalla S, Klein C, Paetsch I, Lehmkuhl H, Bornstedt A, Schnackenburg B, Fleck E, Nagel E (2002) Real-time MR image acquisition during high-dose dobutamine hydrochloride stress for detecting left ventricular wall-motion abnormalities in patients with coronary artery disease. Radiology 224:845–851

    PubMed  Google Scholar 

  21. Poldermans D, Fioretti PM, Boersma E, Bax JJ, Thomson IR, Roelandt JRTC, Simoons ML (1999) Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with proven or suspected coronary artery disease. Circulation 99:757–762

    CAS  PubMed  Google Scholar 

  22. Taillefer R, Ahlberg AW, Masood Y, White CM, Lamargese I, Mather JF, McGill CC, Heller GV (2003) Acute beta-blockade reduces the extent and severity of myocardial perfusion defects with Dipyridamole Tc-99m Sestamibi SPECT imaging. J Am Coll Cardiol 42:1475–1483

    Article  CAS  PubMed  Google Scholar 

  23. Miller RR, Olson HG, Amsterdam EA, Mason DT (1975) Propranolol withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy. N Engl J Med 293:416–418

    CAS  PubMed  Google Scholar 

  24. Lindenfeld J, Crawford MH, O’Rourke RA, Levine SP, Montiel MM, Horwitz LD (1980) Adrenergic responsiveness after abrupt propranolol withdrawal in normal subjects and in patients with angina pectoris. Circulation 62:704–711

    CAS  PubMed  Google Scholar 

  25. Myers MG, Wisenberg G (1977) Sudden withdrawal of propranolol in patients with angina pectoris. Chest 71:24–26

    CAS  PubMed  Google Scholar 

  26. Kasser IS, Bruce RA (1969) Comparative effects of aging and coronary heart disease on submaximal and maximal exercise. Circulation 39:759–774

    CAS  PubMed  Google Scholar 

  27. Blomqvist CG (1971) Use of exercise testing for diagnostic and functional evaluation of patients with arteriosclerotic heart disease. Circulation 44:1120–1136

    CAS  PubMed  Google Scholar 

  28. Elhendy A, van Domburg RT, Bax JJ, Nierop PR, Geleijnse ML, Ibrahim MM, Roelandt JRTC (1999) The functional significance of chronotropic incompetence during dobutamine-stress test. Heart 81:398–403

    CAS  PubMed  Google Scholar 

  29. Wintersperger BJ, Nikolaou K, Dietrich O, Rieber J, Nittka M, Reiser MF, Schoenberg SO (2003) Single breath-hold real-time cine MR imaging: improved temporal resolution using generalized autocalibrating partially parallel acquisition (GRAPPA) algorithm. Eur Radiol 13:1931–1936

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

We are indebted to Dr W.J. Post for data analysis.

Author information

Authors and Affiliations

  1. Department of Radiology, State University and Academic Hospital Groningen, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands

    Dirkjan Kuijpers, Caroline H. C. Janssen & Matthijs Oudkerk

  2. Department of Radiology and Cardiology, Bronovo Hospital, Bronovolaan 1, P.O. Box 96900, 2597 AX, The Hague, The Netherlands

    Dirkjan Kuijpers & Paul R. M. van Dijkman

Authors
  1. Dirkjan Kuijpers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Caroline H. C. Janssen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Paul R. M. van Dijkman
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Matthijs Oudkerk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dirkjan Kuijpers.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuijpers, D., Janssen, C.H.C., van Dijkman, P.R.M. et al. Dobutamine stress MRI. Part I. Safety and feasibility of dobutamine cardiovascular magnetic resonance in patients suspected of myocardial ischemia. Eur Radiol 14, 1823–1828 (2004). https://doi.org/10.1007/s00330-004-2425-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-004-2425-y

Keywords

Search

Navigation